Rohit from Deutschland applies for Blue Card Germany

Biologists, botanists, zoologists and related professionals

Personal data:

For personal data please contact us
with the following Applicants-ID: 12928


Name of profession: Biologists, botanists, zoologists and related professionals Name of latest business sector: Charité – Universitätsmedizin Berlin Latest occupation/title: Senior Post Doctoral Fellow (Dr ) Latest main activities: Supervising one PhD student in a project ‘ Role of mast cell mediated IL-33 in asthma’. Independently designed and performed experiments to successfully identify the role of IL-33 in modulation of mast cell function. Regularly presented data at group


Completed education: doctoral Title or Qualification: Dr Specialisation: Allergy and Immunology Additional trainings: Post Doctoral Diploma from Karolinska Institutet , Stockholm , Sweden

Preferred countries:

1. Preferred country | region / city: Germany | Berlin 2. Preferred country | region / city: Sweden | Stockholm 3. Preferred country | region / city: Austria | vienna

Language skills:

1. Language skills: english => excellent 2. Language skills: 3. Language skills: Hindi => excellent

Personal note /detailed application:

Application for EU Blue card

Personal information
Date of Birth 20-10-1978
Web Page
Current Occupation
Designation: Post Doctoral Researcher at Deptt. Of Dermatology and Allergy, Universitätsmedizin Berlin
Principal Investigator Prof Marcus Maurer
Research Topic/ Subject: Characterization of mast cell function in allergy and Inflammation.
Duration of first Post-doctoral Research Two years (23-03-2009 to 30-6-2011)
Duration of Second Post-doctoral Research (21-07-2011 to till date)
Current Research Subject/Area Immunology, Infection biology, IL-33, Allergy, Asthma Immunology, Allergic rhinitis, Mast cell biology, Biochemistry and Cell Biology.
Previous occupation
Designation: Post doctoral fellow at Karolinska Institute, Stockholm, Sweden
PhD or doctoral student as CSIR Junior research Fellow (7.01.2003 to 06-01-2005) and CSIR Senior Research Fellow (7.01.2005 to 10-11-2008)

Discipline/subject area Immunology, Biochemistry, Life Science (Cardiovascular Biology, Nitric Oxide synthase, Blood Cells)
Educational qualifications: PhD (Life Sciences)

Title of Doctoral thesis: `Molecular and Biochemical Studies on Nitric Oxide Synthase in Polymorphonuclear Leukocytes under Normal and Pathological Conditions`.
Date of Thesis Defense: 10-10-2008

Personal achievements
Awards and Fellowships:
1. Travel Grant award for 9th EAACI-GA2LEN Winter School “Basic Immunology Research in Allergy and Clinical Immunology” in Davos, February 3-6, 2011 Davos Switzerland.
2. Erasmus Mundus External Cooperation Window Lot 15 India –European Commission 2009 (EM-ECW Lot 15 India).
3. Council for Industrial and Scientific Research, National Eligibility test Junior Research Fellow, (CSIR-NET-JRF 2002).
4. Council for Industrial and Scientific Research, National Eligibility test Senior Research Fellow, (CSIR-NET-SRF 2004).
5. Graduate Aptitude Test in Engineering (GATE 2002) qualified [All India rank 35] in Life Sciences.

Potential of training and teaching: I have previous experience during PhD to design and supervise projects for graduate students coming to our lab for a semester to do their thesis work. I have experience to guide and co supervise various students during their thesis of M.Sc and M.Pharm. Presently I am supervising a PhD student as his main supervisor.

Invited lecture:
1. Toll like receptor ligand exposure time dependently primes Mast cell for FC?R1 induced responses, College of Applied Education & Health Sciences, Meerut, India, 5 November, 2010.

2. Mast Cell Reactivity in Allergy and Inflammation, All India institute of Medical Sciences, Bhopal, India, 28 Jan 2013.

Reviewer of Editorial Board:

1. Indian Journal of Dermatology, Venereology and Leprology (
2. Indian Journal of Dermatology (
3. Indian Dermatology Online Journal (
4. Indian Journal of Experimental Biology (
5. Lung India (
6. Journal of Natural science Biology and medicine (
7. International Journal of Applied and Basic Medical Research (
8. Chronicles of Young Scientists (
9. Journal of emerging investigators (
10. Clinical and Translartional allergy (

1. Member of European Academy of Allergy and Clinical Immunology ( EAACI)
2. Member of European Mast Cell and Basophil Research Network (EMBRN).
3. Member of Mast cell Network (Mac Net)
4. Inflammation and Immunology Network (KiiM)
5. Centre for Allergy Research (CfA)

Technical Expertise:
Cell Culture- Cell culture of Neutrophils, Bone marrow derived mast cells (BMMC), Connective tissue like mast cells (CTLMC), Mucosal like mast cells (MLMC), Peritoneal culture mast cell ( PCMCS), human cord blood mast cells (CBMCs), HMC1.1, LAD2, epithelial cells ( A549, 9HTEO)
Molecular biology techniques: RT PCR, Real Time PCR (Sybr green),Taqman real time PCR, Cloning and expression of the genes, Isolation and purification of plasmid and genomic DNA, Transformation, Restriction Digestion of DNA, SDS-poly acryl amide gel electrophoresis, Native-poly acryl amide gel electrophoresis, cell culture, Southern-blot, Immunoprecipitation and Western-blot, Electrophoretic Mobility Shift Assays (EMSA).
Scanning Electron Microscopy: Neutrophil Extracellular Trap (NET) formation
Transmission electron microscopy: Ultra-structural study of peripheral blood cells and intracellular localization of NOS isoforms in them.
Biochemical Estimations:
Enzyme catalysis: Nitric oxide synthase in peripheral blood cells, myeloperoxidase in neutrophils, ? hexosaminidase activity and Histamine measurement in mast cells
Enzyme purification: Nitric oxide synthase by using ADP sepharose column
Quantification: Nitrite/ Protein associated/ Total Nitrite estimation, Amino acids, DNA, RNA, Protein
ELISA: Measurement IL-33 in Asthmatic patient’s BAL fluid as well as in serum, measurement of Cystenyl leukotrienes (Cys LT) and leukotrirenes B4 (LTB4) in culture supernatant.
Multiplex ELISA: Measurement of 10 different cytokine and chemokine in mast cell culture supernatant
Confocal/Immunofluorescence Microscopy: Intracellular protein labeling and localization
Animal Handling: Certificate course in animal handling: FELASA Germany (Federation of Laboratory Animal Science Associations)
Computer Proficiency: Good commanding on MS Office, and Windows Operating System. Good command on exploring databases and retrieval of biological information’s through Internet. Documentation of image, Processing, Data analysis using UVP as well as Alfa-imager Gel documentation system with Power PC as work station. MS Excel, Adobe system- Photoshop, Image ready & Acrobat reader.
Bioinformatics tools used: INTERNET, NCBI, BLAST, ExPASy, Swiss-Prot, ENTREZ, FASTA & Uni Gene Search for sequencing, Pub Med, Cluster analysis, and Chem finder.
Publication list:
Research Articles:

1. Lundstrom S*, Saluja R*,Wheelock C , Haeggström J Z , Nilsson G, Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations. J Lipid Res. 2013 54(1):116-26 * equal contribution.( Impact factor =6.1).
2. Saluja R, Delin I, Nilsson GP, Adner M. Fc?R(1)-Mediated Mast Cell Reactivity Is Amplified through Prolonged Toll-Like Receptor-Ligand Treatment. PLoS One. 2012;7(8):e43547. (Impact factor =4.4).
3. Saluja R, Jyoti A, Chatterjee M, Verma A, Bajpai V. K. and Dikshit M., Molecular and Biochemical Characterization of Nitric Oxide Synthase Isoforms and their Intracellular Distribution in Human PBMCs. BBA Mol Cell Res, 1813 (2011) 1700-1707. (Impact factor =4.7)

4. Saluja R, Saini R, Bajpai V. K. and Dikshit M, Ultrastructural immunogold localization of nitric oxide synthase isoforms in rat and human eosinophils.Cell and Tissue Research 340 (2010) 381-8. (Impact factor =2.8)
5. Chatterjee M, Saluja R, Kumar V, Jain GK and Dikshit M. Ascorbate sustains neutrophil NOS expression, catalysis and oxidative burst. Free Radic Biol Med. 45 ( 2008) 1084-93. (Impact factor =5.7)
6. Chatterjee M, Saluja R , Kanneganti S, Chinta S, Dikshit M, Biochemical and Molecular evaluation of neutrophil NOS in spontaneously hypertensive rats, Cell. Mol.Biol.53 (2007) 84-93. (Impact factor =1.4)
7. Chatterjee M, Saluja R, Tiwari S, Goel SK , Barthwal MK, Dikshit M. Augmented Nitric Oxide Generation in Neutrophils: Oxidative and Pro-inflammatory Implications in Hypertension. Free Radical Research, 43 (2009) 1195-1204. (Impact factor =2.8)
8. Saini R, Patel S, Saluja R, Sahasrabuddhe AA, Singh MP, Habib S, Bajpai VK, Dikshit M , Nitric oxide synthase localization in the rat neutrophils: immunocytochemical, molecular and biochemical studies, J.Leukoc.Biol. 79 (2006) 519-528. (Impact factor =4.6)
9. Patel S, Kumar S, Jyoti A, Srinag BS, Keshari RS, Saluja R, Verma A, Mitra K, Barthwal MK, Krishnamurthy H, Bajpai VK, Dikshit M. Nitric oxide donors release extracellular traps from human neutrophils by augmenting free radical generation. Nitric Oxide. 22 (2010) 226-234. (Impact factor =3.3)
10. Kothari H, Kumar P, Saluja R, Sundar S, Singh N. Translation of open reading frame in kinetoplast DNA minicircles of clinical isolates of L. donovani. Parasitol Res. 2007 ;100(4):893-7. (Impact factor =1.8)

Review Article:

1. Kavya R, Saluja R, Singh S, Dikshit M, Nitric oxide synthase regulation and diversity: implication in Parkinson’s disease, Nitric Oxide 4 (2006) 280-294. ( Impact factor = 3.3)
2. Saluja R, Metz M, Maurer M. Role and relevance of mast cells in fungal infections. Front Immunol. 2012;3:146.

Book Chapter:
1. Bhargav P and Saluja R*, Chapter: Microbial interaction with metal pollutants, Book Name: Environmental Science: Role of Microbes in current scenario. Lamberta Publishing House Germany. * Corresponding author
2. Saluja R*, Mast cell Toll-like receptors (TLRs), European Mast Cell and Basophil Research Network (EMBRN), wikipedia, 2013, * Corresponding author mast-cell-tlr/
Paper Communicated/ under preparation:
1. Enoksson M , Andersson C, Heinz G, Chatterjee M, Saluja R, Erjefalt J, Nilsson G, Lunderius-Andersson C. Human mast cell responses to injured airway epithelial cells-implication for chronic airway inflammation. (Manuscript communicated)
2. Saluja R , Palmberg L, Dahlen B , Larsson K , Nilsson G . IL-33 and soluble ST2 in bronchoalveolar lavage fluid from acute and chronic respiratory inflammations. ( Manuscript under preparation).
3. Saluja R , Worm M, Maurer M. Serum levels of IL-33 and its receptor ST2 in patients with atopic dermatitis, mastocytosis and prurigo nodularis. (Manuscript under preparation).
4. Saluja R , Eberle J, Maurer M , Interleukin-33 promotes proliferation of mouse mast cells through c-Kit and p38 MAPK -dependent pathway. (Manuscript under preparation).
5. Saluja R , Zhao Z, Li L, Li R , Maurer M , Characterizing The Protective Roles of Mast Cells Against Sporothrix schenckii Infection (Manuscript under preparation).
1. Tripathi MK, Saluja R, Gaur AK and Mishra DP. Identification of photosynthetic and biochemical character(s) associated with isoproturon resistance in Phalaris minor. 71st Annual Meeting, Society of Biological Chemist held at Punjab Agriculture University, 2002, Ludhiana, India.

2. Saluja R, Bajpai VK, Mitra K, Habib S,Dikshit M. Molecular characterization and distribution of NOS in human blood cells, Emerging Trends in Free Radical and Antioxidant research (Society Of Free Radical Research), 2007 , Lonavala, India.
3. Patel S, Kumar S, Saluja R, Barthwal MK, Mitra K, Verma A, Bajpai VK, Dikshit M. Neutrophil extracellular trap formation by nitric oxide donors: Involvement of nitric oxide synthase and myeloperoxidase derived free radicals. FASEB J 2008 ,22:1072.9.

4. Saluja R, Delin I, Adner M , Nilsson G. Mast Cell Reactivity in Allergy and Inflammation, (Oral presentation) Kiim retreat, Oct 8-9, 2009 , Sånga Säby, Stockholm, Sweden.
5. Saluja R, Delin I, Adner M , Nilsson G. Toll Like Receptor (TLR) mediated augmentation of IgE-dependent mast cell activation. Feb 11-14, 2010, 8th EAACI-GA²LEN Immunology , Grainau , Germany
6. Saluja R, Delin I, Adner M , Nilsson G. Toll Like Receptor (TLR) mediated augmentation of IgE-dependent mast cell activation. Feb 17-18. Institutionskonferens , Utsikten, Nynashaman. Stockholm.
7. Nilsson G, Saluja R, and Adner M. Infections affect mast cell reactivity- possible implication for asthma exacerbation. World immune regulation meeting IV (WIRM); Davos, Switzerland 29 march – 1 Apr 2010
8. Saluja R, Delin I, Adner M , Nilsson G. Differential phenotypic expression of TLRs correlates with distinct functional response among mast cells . Kick off meeting of Clinical Immunology and Allergy unit. Sep 21, 2010 Radisson Blue Royal park hotel.
9. Saluja R, Delin I, Adner M , Nilsson G. FC?R1 Triggered Mast Cell Responses Are Time Dependently Enhanced by Toll Like Receptor Ligand Exposure, National symposium on "Modern Approaches and Innovations in Biotechnology" November 14-15, 2010. College of Applied Education & Health Sciences, Roorkee Road, Meerut , India
10. Jyoti A, Saluja R, Kumar S, Chatterjee M, Verma A, Barthwal MK, Bajpai VK and Dikshit M, Molecular, biochemical characterization and localization of neuronal nitric oxide synthase in human neutrophil. FASEB J , 2010, 24, 984.17
11. Saluja R, Delin I, Adner M , Nilsson G. Infections affect mast cell reactivity – possible implications for asthma exacerbations,(Oral Presentation), International Mast Cell and Basophil Meeting December 9-10, 2010, Berlin, Germany
12. Saluja R, Delin I, Adner M , Nilsson G. Mast cell Fc?RI responses are time dependently enhanced by Toll-like receptor ligand exposure (Oral Presentation) 9th EAACI-GA2LEN Winter School “Basic Immunology Research in Allergy and Clinical Immunology” in Davos, February 3-6, 2011 Davos Switzerland.
13. Saluja R, Delin I, Adner M , Nilsson G. Fc?R1 –mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment KiiM- KIRCNET Retreat ( Poster Presentation ) March 24-25, 2011, Stockholm Sweden.
14. Saluja R, Delin I, Adner M , Nilsson G. Fc?R1 –mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment EMBRN Meeting. ( Poster Presentation ) November 24- 25 2011, Southampton, UK .
15. Saluja R, Delin I, Nilsson GP, Adner M. Fc?R(1)-Mediated Mast Cell Reactivity Is Amplified through Prolonged Toll-Like Receptor-Ligand Treatment. Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF). (Oral Presentation) March 1st -3rd 2012. Marburg, Germany.

16. Saluja R, Eberle J, Maurer M. Interleukin-33 promotes proliferation of mouse mast cells EMBRN Meeting. (Poster Presentation) November 26- 27, 2012, Berlin, Germany.
17. Jyoti A, Singh A, Keshari R, Kumar S, Saluja R, Dubey M, Verma A, Bajpai V, Barthwal M K, Anil K Tripathi AK, and Dikshit M, Nitric Oxide Synthase - Nitric Oxide Involvement in the Human Neutrophil Free Radical Generation: Role of iNOS and Rac2 Interaction. Blood 2012 120: 1036

Summary of Present Post doctoral Research:
Presently I am working with Prof Marcus Maurer, Professor of Dermatology and Allergy and Director of Research in Department of Dermatology and Allergy at Charité – Universitätsmedizin Berlin. My research work is focus on role of IL-33 on mast cell functions.

Interleukin-33 (IL-33), a member of the IL-1 cytokine family, is emerging as a new regulator of immune responses and inflammatory diseases. IL-33 signals via a heterodimer composed of IL-1 receptor-related protein ST2 and IL-1 receptor accessory protein (IL-1RAcP). IL-33 has been shown to activate T helper 2 cells (Th2), mast cells and basophils to produce a variety of Th2 cytokines and mediate allergic-type immune responses. Although IL-33 and its associated receptor ST2 appear to be expressed in mast cells, the precise role of IL-33 in modulation of mast cell function has not been determined. For the present studies, we employed in vitro differentiated bone marrow derived mast cells (BMMCs) from C57BL/6 mice. BMMCs were treated for 24 h to 96 h with different concentrations of IL-33 and then checked for degranulation, cell proliferation, cytotoxicity, cell survival and apoptosis. Our result indicates that IL-33 did not induce degranulation on mast cell, as measured by ?-hexosaminidase release, but it resulted in increased proliferation of BMMCs, as determined by WST assay. Cell cycle analysis further confirmed the result as showing increased G2 cell populations in flow cytometry after propidium iodide staining. Cytotoxicity was unaffected at different times (24 to 96 h), as determined by lactate dehydrogenase (LDH) release in cell culture supernatants. Similarly, no effect was obtained by IL-33 on cell viability, as assessed by staining with the fluorescent dye calcein-AM. We further instigate that IL-33 mediated mast cell proliferation is dependent on receptor tyrosine kinase c-Kit and mediated through a p38 MAPK -dependent pathway. We report here a novel role of IL-33 as an inducer of mast cell proliferation through c-Kit and p38 MAPK-dependent pathway. The findings may open new perspectives for understanding the role of IL-33 in different allergic diseases associated with mast cells.

Summary of previous Post Doctoral Research: I have done my previous post doctoral research work with Prof Gunnar Nilsson at Karolinska Institute who has been working in asthma immunology and allergic inflammation since last 20 years.
In one project I have explored mast cell reactivity in allergy, inflammation and the effect of bacterial and viral infections on IgE-mediated mast cell reactivity employing in vitro differentiated connective tissue like mast cells (CTLMC) and mucosal like mast cells (MLMC). They were pre-treated with toll like receptor (TLR) ligands before sensitization with IgE and subsequent Fc?R1 aggregation. Difference in expression of different TLR subtypes was evident among the two mast cell subtypes, however exposure to TLR subtype specific ligands did not affect the expression pattern of TLRs. Culture of CTLMC and MLMC in presence of TLR specific ligands for short or long duration followed by sensitization with IgE, and antigen induced activation revealed that prolonged pre-exposure with TLR ligands exerbated mast cell reactivity after IgE-receptor aggregation assessed by release of ? hexosaminidase, cysteinyl leukotriens and LTB4. The extent of reactivity also varied between MLMCs and CTLMCs. LPS induced TLR4 mediated pathway was found to be MyD88-dependent as verified in MyD88-/- mice and enhancement of mediator release involved the signaling intermediates JNK/SAPK. Therefore, prolonged exposure of mast cells to pathogens/TLR-ligands primes them for increased release of inflammatory mediators when they are activated by IgE-receptor aggregation and this could provoke exacerbation of allergic diseases associated with infection.
In another project that deals with IL-33, I am exploring epithelial cell injury induced activation of mast cell and decipher possible involvement of IL-33 in asthma. Previous study from this lab in mouse model indicates that injured cells release IL-33 causing mast cell cytokine release. Since IL-33 is an important factor for the allergic inflammation, I have measured IL-33 level in bronchoalveolar lavage (BAL) fluid from asthmatic as well as COPD patients to correlate with disease severity also among smokers and non-smokers. To investigate role of IL-33 in prompting activation of mast cells during lung inflammatory response I have explored expression of IL-33 receptor ST2 at basal stage as well as after treatment of mast cell with TNF-? and IL-1?. I am also exploring epithelial cell injury induced activation of mast cell activation. In asthma, damaged airway epithelial cells undergo necrosis releasing damage associated molecular patterns (DAMPs) that alert the immune system. The question to address first is which of the DAMPs are recognized by the mast cell and the consequences of this activation in the liberation of inflammatory mediators. I treat CBMCs with different known DAMPs, and necrotic cells from primary lung epithelial cells and lung epithelial cell lines. I have measured release of mast cell mediators and explored the receptors expressed on mast cells that recognize these danger signals. Based on preliminary data from our mouse studies, we hypothesize that the IL-33 receptor ST2, expressed on mast cells is involved in the activation of mast cells.

Summary of Doctoral Research: My dissertation was planned with the objective to evaluate the human and rat Nitric oxide synthase (NOS) from a biochemical and molecular perspective in normal physiological and pathological conditions (spontaneous hypertension, Vitamin C deficiency). I have showed the presence of full length NOS isoforms (nNOS, iNOS and eNOS) at both transcript and protein levels among peripheral blood cells from healthy subjects. Although iNOS expression was constitutive in human neutrophils, further stimulation with LPS lead to the up regulation of iNOS transcription, which was mediated through NF?B. Neutrophils exhibited maximal NO generation potential as compared to PBMCs, platelets and RBCs. NOS catalysis using radioactive substrate showed that Neutrophils and PBMCs exhibited equivalent levels of NOS catalysis, while NOS activity was less in RBCs. Most of the NOS activity in neutrophils, and RBCs was calcium dependent (nNOS and eNOS) while PBMCs and platelets showed significant contribution of inducible NOS to the overall catalytic output. NOS (nNOS, iNOS and eNOS) distribution exhibited cell specific subcellular localization in neutrophils, PBMCs, platelets and RBCs as evidenced electron microscopic observations and morphometric analysis. NOS isoforms were localized to cytoplasm, nucleus, and plasma membrane in different blood cells. NOS was found in primary granules and mitochondria of neutrophils, while in platelets NOS was localized in dense granules, alpha granules and open canalicular system.
I have also explored Neutrophil extracellular traps (NETs) formation in response to NO donors in both rat and human neutrophils by scanning electron microscopy. I found that NO can instigate neutrophils to form NETs as a mode of antimicrobial action against pathogenic intrusion which could have important implication during inflammatory conditions. Besides I have evaluated the impact of neutrophil NOS in pathophysiological conditions like -LPS induced sepsis model, spontaneously hypertensive rats and Vitamin C deficiency.

Seminars & Symposia attended:
1. Work shop on Drafting a patent application, 2002, Indian Institute of Technology (IIT) Roorkee , India
2. Training workshop on scientific communication, 2004 , Industrial Toxicology Research Centre , Lucknow, India
3. 3rd Global Meet on Parasitic Diseases , 2004, Bangalore, India
4. Workshop on Nanoscale Imaging and detection of Biomolecules, 2005 ,Chennai, India
5. Biomedical communication and Intellectual Property Right, 2006, King George Medical University, Lucknow, India
6. Emerging Trends in Free Radical and Antioxidant research (Society Of Free Radical Research), 2007 , Lonavala, India
7. 2nd MacNet Meeting in Åre, 2009, Stockholm Sweden
8. General introduction to Karolinska Institutet and Life in Sweden, Karolinska Institutet ,2009, Stockholm , Sweden
9. Course work on Docentur Application-How to become a docent? , Karolinska Institutet, 2009, Stockholm, Sweden
10. Marie Curie Crash course, How to write a successful application, Karolinska Institutet, 2009, Stockholm, Sweden.
11. Phenotypic characterization of mast cell and deciphering their differential role in asthma and inflammation, Project review meeting, Oct 15, 2009, Stockholm, Sweden.
12. Mast Cell Reactivity in Allergy and Inflammation, Kiim retreat, Oct 8-9, 2009 , Sånga Säby, Stockholm, Sweden.
13. Luminex Workshop, Karolinska institutet , Huddinge, Nov 4 , 2009, Stockholm, Sweden.
14. Seminar on Principles of Scientific Writing by Angelika Hofmann from Yale University Dec 9 , 2009 , Karolinska Institutet , Stockholm , Sweden
15. Bioplex user Meeting Stockholm 11 may 2010
16. Bradykinin in Health and disease , Berlin 23-24 august 2012


Prof Sudhir Kumar Goel
Head, Department of Biochemistry
All India Institute of Medical Sciences Bhopal
Saket Nager,Bhopal-462 024 ( India) ,
E Mail :

Prof Gunnar Nilsson
Department of Medicine Solna
Clinical Immunology and Allergy Unit
Karolinska University Hospital Solna L2:04
SE - 171 76 Stockholm, Sweden
E Mail:

Prof Marcus Maurer
Dpt. of Dermatology and Allergy
Charité – Universitätsmedizin Berlin
Charitéplatz 1
D-10117 Berlin, Germany
E Mail:


Google Plus